HYDERABAD, India--(BUSINESS WIRE)--Dr. Reddy's Laboratories (BSE: 500124) (NSE: DRREDDY) (NYSE: RDY) will hold a Conference Call on November 9, 2015 to clarify investors’ queries on the Warning Letter issued by the US FDA dated November 05, 2015.
Audio Webcast
The audio webcast of the call will be available to all interested parties at www.drreddys.com. Please visit the web site at least fifteen minutes ahead of the scheduled start time to register and to download and install any necessary audio software. Participants in the webcast can listen to the proceedings, but will not be able to ask questions. The replay will be available 2 hours after the call, through Nov 13, 2015. For play back dial in phone No: 022 3065 2322, 022 61813322 and ID: 375#.
Transcript
The transcript of the call will also be available on the Company's website.
| Conference Dial-In Numbers | ||
| Primary Number: | +91 22 3960 0616 | |
| Secondary Number: | +91 22 6746 5826 | |
| The numbers listed above are universally accessible from all networks and all countries. | ||
| Local Access Number: |
6000 1221 Available in - - Ahmedabad, Bangalore, Bhubaneswar, Chandigarh, Chennai, Coimbatore, Delhi, Goa, Guntur, Gurgaon, Hyderabad, Indore, Jamshedpur, Kanpur, Kochi/Cochin, Kolhapur, Kolkata, Nagpur, Noida, Patna, Pune, Raipur, Rajkot, Surat, Trivandrum, Vadodara, Vijayawada Accessible from all major carriers except BSNL/MTNL. 3940 3977 Available in Ahmedabad, Bangalore, Chandigarh, Chennai, Kochi/Cochin, Gurgaon (NCR), Hyderabad, Kolkata, Lucknow, Pune Accessible from all carriers. |
|
| International Toll Free Number: |
USA: 1 866 746 2133 UK: 0 808 101 1573 Singapore: 800 101 2045 Hong Kong: 800 964 448 |
|
No password/pin number is necessary to dial in to any of the other calls. As participation in the call is limited, early registration is encouraged. The operator will provide instructions on asking questions before and during the call.
